Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€4.67

€4.67

0.090%
0.004
0.090%
-
 
08.08.25 / Tradegate WKN: A2P71U / Name: Curevac / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Curevac N.V. Stock

There is nearly no change for the Curevac N.V. stock today. Compared to yesterday it only changed by €0.004.
For the coming years our community has positive and negative things to say abot the Curevac N.V. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of Curevac N.V. in the next few years

Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Sell Curevac N.V.
Show more

Buy Curevac N.V.
Show more

Buy Curevac N.V.
Show more

News

EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech
EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech
EQS-News: CureVac Announces Voting Results of General Meeting: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Announces Voting Results of General Meeting
EQS-News: CureVac Announces Voting Results of General Meeting
CureVac Stock: BioNTech's Billion-Dollar Takeover Bid
CureVac Stock: BioNTech's Billion-Dollar Takeover Bid

The biotech landscape was shaken Thursday as BioNTech announced a takeover offer for Tübingen-based CureVac, valuing the company at approximately $1.25 billion (€1.08 billion). Under the proposed